Essential Medicines Strategic Stockpile Act of 2023
Summary
Essential Medicines Strategic Stockpile Act of 2023 This bill requires the Department of Health and Human Services (HHS) to create a pilot program to test the effectiveness of acquiring, maintaining, managing, and distributing a stockpile of generic drugs at risk of shortage. To carry out the pilot program, HHS must enter into contracts for a term of up to three years with drug manufacturers, co-op or chain pharmacy warehouses, or other eligible entities to create a six-month stockpile of up to 50 types of such drugs. The bill establishes various program requirements, including annual evaluations by the Government Accountability Office.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2023
Committee Review
Floor Vote
President
Introduced Jan 20, 2023
Last action Jan 27, 2023
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
0
Committee
2
Jan 27, 2023
Committee
Referred to the Subcommittee on Health.
lower
Jan 20, 2023
Committee
Referred to the House Committee on Energy and Commerce.
lower
Jan 20, 2023
Introduced
Introduced in House
lower
1 primary · 3 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Earl L. "Buddy" Carter
RRepublican
Co
Diana Harshbarger
RRepublican
Co
Lisa Blunt Rochester
DDemocratic
Co
Nancy Mace
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 405
Scope: US
Hi! I can help you understand HR 405. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline